RT Journal Article
SR Electronic
T1 Implementation of Agile in health care: Methodology for a multi-site home hospital accelerator
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.12.23299864
DO 10.1101/2023.12.12.23299864
A1 Desai, Meghna
A1 Tardif-Douglin, Miriam
A1 Miller, Indigo R. D.
A1 Blitzer, Stephanie C.
A1 Gardner, David L.
A1 Thompson, Teresa M.
A1 Edmondson, LaPonda
A1 Levine, David M.
YR 2023
UL http://medrxiv.org/content/early/2023/12/14/2023.12.12.23299864.abstract
AB Background The diffusion of innovation in health care is sluggish. Evidence-based care models and interventions take years to reach patients. We believe the health care community could deliver innovation to the bedside faster if it followed other sectors by employing an organizational framework for efficiently accomplishing work. Home hospital is an example of sluggish diffusion. This model provides hospital-level care in a patient’s home instead of in a traditional hospital with equal or better outcomes. Home hospital uptake has steadily grown during the COVID-19 pandemic, yet barriers to launch remain for health care organizations, including access to expertise and implementation tools. The Home Hospital Early Adopters Accelerator was created to bring together a network of health care organizations to develop tools necessary for program implementation.Methods The Accelerator used the Agile framework known as Scrum to rapidly coordinate work across many different specialized skill sets and blend individuals who had no experience with one another into efficient teams. Its goal was to take 40 weeks to develop 20 “knowledge products,” or tools critical to the development of a home hospital program such as workflows, inclusion criteria, and protocols. We conducted a mixed methods evaluation of the Accelerator’s implementation, measuring teams’ productivity and experience.Results Eighteen health care organizations participated in the Accelerator to produce the expected 20 knowledge products in only 32 working weeks, a 20% reduction in time. Nearly all (97.4%) participants agreed or strongly agreed the Scrum teams worked well together, and 96.8% felt the teams produced a high-quality product. Participants consistently remarked that the Scrum team developed products much faster than their respective organizational teams. The Accelerator was not a panacea: it was challenging for some participants to become familiar with the Scrum framework and some participants struggled with balancing participation in the Accelerator with their job duties.Conclusions Implementation of an agile-based accelerator that joined disparate health care organizations into teams equipped to create knowledge products for home hospital proved both efficient and effective. We demonstrate that implementing an organizational framework to accomplish work is a valuable approach that may be transformative for the sector.Competing Interest StatementThe other authors declare that they have no competing interests. Dr. David Levine reports the following: Biofourmis: PI-initiated study and codevelopment; IBM: PI-initiated study; Fees from The MetroHealth System.Funding StatementThis study was funded by a grant from CaroNovaAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Mass General Brigham granted exemption for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets generated and/or analyzed during the current study are not publicly available due to individual privacy concerns but are available from the corresponding author upon reasonable request.CMSCenters for Medicare and Medicaid ServicesDevDeveloperPOProduct OwnerREDCapResearch Electronic Data CaptureSDStandard DeviationSMScrum Master